| Mean platelet volume: A link between thrombosis and inflammation? AY Gasparyan, L Ayvazyan, DP Mikhailidis, GD Kitas Current pharmaceutical design 17 (1), 47-58, 2011 | 1089 | 2011 |
| The role of aspirin in cardiovascular prevention: implications of aspirin resistance AY Gasparyan, T Watson, GYH Lip Journal of the American College of Cardiology 51 (19), 1829-1843, 2008 | 345 | 2008 |
| Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors AY Gasparyan, L Ayvazyan, H Blackmore, GD Kitas Rheumatology international 31 (11), 1409-1417, 2011 | 200 | 2011 |
| Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-α therapy AY Gasparyan, A Sandoo, A Stavropoulos-Kalinoglou, GD Kitas Rheumatology international 30 (8), 1125-1129, 2010 | 171 | 2010 |
| Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications AY Gasparyan, A Stavropoulos-Kalinoglou, DP Mikhailidis, KMJ Douglas, ... Rheumatology international 31 (2), 153-164, 2011 | 143 | 2011 |
| Diversity, value and limitations of the journal impact factor and alternative metrics L Bornmann, W Marx, AY Gasparyan, GD Kitas Rheumatology International 32 (7), 1861-1867, 2012 | 128 | 2012 |
| The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases AY Gasparyan, A Stavropoulos-Kalinoglou, DP Mikhailidis, TE Toms, ... Current Vascular Pharmacology 8 (4), 437-449, 2010 | 111 | 2010 |
| Association of mean platelet volume with hypertension in rheumatoid arthritis AY Gasparyan, A Stavropoulos-Kalinoglou, TE Toms, KMJ Douglas, ... Inflammation & Allergy-Drug Targets 9 (1), 45-50, 2010 | 101 | 2010 |
| Behçet’s disease as a model of venous thrombosis M La Regina, AY Gasparyan, F Orlandini, D Prisco The Open Cardiovascular Medicine Journal 4, 71-77, 2010 | 66 | 2010 |
| Authorship problems in scholarly journals: considerations for authors, peer reviewers and editors AY Gasparyan, L Ayvazyan, GD Kitas Rheumatology International 33 (2), 277-284, 2013 | 64 | 2013 |
| Aspirin and clopidogrel resistance: methodological challenges and opportunities AY Gasparyan Vascular Health and Risk Management 6, 109-112, 2010 | 62 | 2010 |
| Adverse Cardiovascular Effects of Antirheumatic Drugs: Implications for Clinical Practice and Research AY Gasparyan, L Ayvazyan, G Cocco, GD Kitas Current Pharmaceutical Design 18 (11), 1543-1555, 2012 | 54 | 2012 |
| Familial Mediterranean fever as an emerging clinical model of atherogenesis associated with low-grade inflammation Ş Yüksel, L Ayvazyan, AY Gasparyan The Open Cardiovascular Medicine Journal 4, 51-56, 2010 | 52 | 2010 |
| Publishing ethics and predatory practices: a dilemma for all stakeholders of science communication AY Gasparyan, M Yessirkepov, SN Diyanova, GD Kitas Journal of Korean medical science 30 (8), 1010-1016, 2015 | 51 | 2015 |
| Biomedical journal editing: elements of success AY Gasparyan, L Ayvazyan, GD Kitas Croatian Medical Journal 52 (3), 423-428, 2011 | 47 | 2011 |
| The pressure to publish more and the scope of predatory publishing activities AY Gasparyan, B Nurmashev, AA Voronov, AN Gerasimov, AM Koroleva, ... Journal of Korean medical science 31 (12), 1874-1878, 2016 | 45 | 2016 |
| Efficacy of remote ischaemic preconditioning for spinal cord protection against ischaemic injury: association with heat shock protein expression O Selimoglu, M Ugurlucan, M Basaran, F Gungor, M Banach, O Cucu, ... Folia Neuropathologica 46 (3), 204-212, 2008 | 45 | 2008 |
| Platelets in rheumatic diseases: friend or foe? A Yuri Gasparyan, L Ayvazyan, E Pretorius, G D Kitas Current pharmaceutical design 20 (4), 552-566, 2014 | 44 | 2014 |
| Cardiovascular Risk and Inflammation: Pathophysiological Mechanisms, Drug Design, and Targets AY Gasparyan Current Pharmaceutical Design 18 (11), 1447-1449, 2012 | 42 | 2012 |
| Self-correction in biomedical publications and the scientific impact. AY Gasparyan, L Ayvazyan, NA Akazhanov, GD Kitas Croatian Medical Journal 55 (1), 61-72, 2014 | 41 | 2014 |
George KitasProfessor of RheumatologyVerified email at dgoh.nhs.uk
